Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

During the Trading Day
54.20 -1.07 / -1.94%
As of 4:03pm ET
Day’s Change
During After-Hours   Switch to standard view »
54.25 +0.0538 / +0.10%
Volume: 4.4K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 3
Quarter 4
Quarter 1
Quarter 2
Operating ActivitiesNet Income / Starting Line1.1B1.1B1.5B1.2B
Total Other Cash Flow903.4M-412.9M-530.2M469.4M
Funds From Operations2.0B1.2B1.0B1.8B
Funds From/For Other Operating Expenses-131.1M-37.6M425.4M26.7M
Net Cash Flow - Operating Activities2.2B1.2B609.9M1.8B
InvestingDecrease In Investments-5.2M-810.3K49.5M178.6M
Capital Expenditures-171.3M-257.9M-113.9M-151.9M
Fixed Asset Disposal-2.9M347.1K342.6M768.9K
Other Investing - Uses0.00-61.2M0.000.00
Other Investing - Sources10.5M-10.5M0.000.00
Net Cash Flow Investing-188.7M-277.7M273.6M8.7M
FinancingShort Term Borrowings0.
Long Term Borrowings0.
Long Term Debt Reduction0.
Net Proceeds Stock Sale0.
Common Preferred Redeemed-696.2M-646.3M-564.3M-589.3M
Common Dividends----------
Cash Dividends Paid - Total33.5M44.0M-1.9B-1.8M
Other Sources - Financing0.000.00347.6M-347.6M
Other Uses - Financing0.
Net Cash Flow - Financing-662.8M-602.2M-2.1B-938.8M
Exchange RateEffect of Exchange Rate on Cash2.8M471.6K19.3M-3.1M
Net Change In Cash1.3B323.7M-1.3B851.0M